Suchergebnisse - "Yuan, Yuan"

PubPharm (7)

1

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Fu, S. | Yao, S. | Yuan, Y. | +17

2

Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer

enthalten in: Cancer | 2023

von Lavasani, S. | Somlo, G. | Yost, S. | +13

3

Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Yuan, Y. | Lee, J. | Yost, S. | +16

4

Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer

enthalten in: Journal of geriatric oncology | 2021

von Yuan, Y. | Lee, J. | Yost, S. | +15

5

Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer

enthalten in: The oncologist | 2021

von Yuan, Y. | Lee, J. | Yost, S. | +19

6

A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer

enthalten in: The oncologist | 2021

von Yuan, Y. | Lee, J. | Yost, S. | +17

7

A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel : Melding the Fields of Geriatrics and Oncology

enthalten in: Clinical breast cancer | 2019

von Hurria, A. | Soto-Perez-de-Celis, E. | Blanchard, S. | +19

1
[1]